The first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the factor XI monoclonal antibody SHR-2004 in healthy subjects

Authors

Zuyi Weng
Yanli Dong (ORCID: https://orcid.org/0000-0002-7919-3276)
Lei Huang (ORCID: https://orcid.org/0000-0001-9464-8577)
Chenxi Shen (ORCID: https://orcid.org/0000-0002-0045-8850)
Kai Shen (ORCID: https://orcid.org/0000-0002-7111-7623)
Juan Li (ORCID: https://orcid.org/0000-0001-8320-2406)
Yuqi Wang (ORCID: https://orcid.org/0000-0002-9793-6002)
Yuanxun Yang
Bei Cao
Chanjuan Deng
Lei Wang (ORCID: https://orcid.org/0000-0001-8751-9216)
Tingting Ma (ORCID: https://orcid.org/0000-0003-3610-5851)

Institutions

Nanjing Drum Tower Hospital (CN)
Jiangsu Hengrui Medicine (China) (CN)
Beijing Proteome Research Center (CN)

Publication Details

Journal: Expert Opinion on Investigational Drugs
Published: 2024-08-21
DOI: https://doi.org/10.1080/13543784.2024.2391837
Citations: 1
Primary Topic: Coagulation, Bradykinin, Polyphosphates, and Angioedema
Type: article
Field-Weighted Citation Impact: 0.44

Funders

National Natural Science Foundation of China

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the factor XI monoclonal antibody SHR-2004 in healthy subjects

Zuyi Weng, Yanli Dong, Lei Huang, Chenxi Shen et al.

Aug 21, 2024

1 citations

Expert Opinion on Investigational Drugs

Coagulation, Bradykinin, Polyphosphates, and Angioedema

0.44

article

The first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the factor XI monoclonal antibody SHR-2004 in healthy subjects

Zuyi Weng, Yanli Dong, Lei Huang, Chenxi Shen, Kai Shen, Juan Li, Yuqi Wang, Yuanxun Yang, Bei Cao, Chanjuan Deng, Lei Wang, Tingting Ma

August 21, 2024article en

1 citations

Abstract

No abstract available for this paper.

Expert Opinion on Investigational DrugsVol. 33(10)

Nanjing Drum Tower Hospital (CN), Jiangsu Hengrui Medicine (China) (CN), Beijing Proteome Research Center (CN)

National Natural Science Foundation of China

Openalex Percentile: Top 34%

Coagulation, Bradykinin, Polyphosphates, and Angioedema

0.44

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.